journal article·2025-11

Headgroup-driven binding selectivity of alkylphospholipids to anionic lipid bilayers

Abebual Molla, Tun Naw Sut, Bo Kyeong Yoon, Joshua A. Jackman

Publisher page

Abstract

Alkylphospholipids (APLs) are single-chain lipid amphiphiles that possess clinically useful, membrane-targeting functions, including anticancer activity. Engineered APLs have diverse headgroup chemistries aimed at improving pharmacological properties yet the impact of these structural differences on membrane interactions is scarcely understood. Herein, we investigated how three representative APLs - miltefosine (MIL), edelfosine (EDE), and perifosine (PER) - interact with supported lipid bilayer (SLB) platforms mimicking the high phosphatidylserine (PS) lipid content of cancer cell membranes and related compositions, and elucidated key interaction principles in terms of headgroup sterics, chain length, binding strength and selectivity, and colloidal aggregation state. Using the quartz crystal microbalance-dissipation (QCM-D) technique, we determined that MIL exhibits strong binding to anionic PS-enriched membranes while binding was suppressed by divalent cations. In contrast, MIL had minimal interactions with cationic membranes, indicating electrostatic-mediated membrane targeting that is distinct from the hydrophobic-driven mechanism of classical surfactants. We found that EDE behaved similarly to MIL and that PER exhibited markedly weaker binding to PS-enriched membranes. Although all three APL headgroups have permanently cationic quaternary amines, only the MIL and EDE headgroups display high conformational flexibility that enables strong binding to PS lipids whereas the PER headgroup has a sterically hindered piperidine ring that limits binding. These findings shed light on the functional importance of APL headgroup chemistry that goes beyond the traditional focus on pharmacological optimization and identify key mechanistic factors that enable selective PS lipid binding relevant to cancer cell targeting. In turn, these insights provide a molecular-level framework for rational APL design and colloidal delivery strategies.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Anticancer mechanisms and clinical application of alkylphospholipids10.1016/j.bbalip.2012.10.008 ↗
2. Alkylphospholipids: An update on molecular mechanisms and clinical relevance10.1016/j.bbamem.2017.02.016 ↗
3. Lysophosphatidylcholine (lysolecithin) and its synthetic analogues. immunemodulating and other biologic effects
4. Testing the hypothesis that amphiphilic antineoplastic lipid analogues act through reduction of membrane curvature elastic stress10.1098/rsif.2008.0041 ↗
5. Edelfosine and miltefosine effects on lipid raft properties: membrane biophysics in cell death by antitumor lipids10.1021/jp401407d ↗
6. Hexadecylphosphocholine: a new and selective antitumor drug10.1016/0305-7372(90)90053-I ↗
7. Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-2013310.1007/BF00685887 ↗
8. D-21266, a new heterocyclic alkylphospholipid with antitumour activity10.1016/S0959-8049(97)89020-X ↗
9. Alkylphosphocholines: a new class of membrane-active anticancer agents10.1007/BF00685608 ↗
10. Phospholipid antitumor agents10.1002/med.2610150302 ↗
11. Interactions of miltefosine with erythrocyte membrane proteins compared to those of ionic surfactants10.1016/j.colsurfb.2019.04.040 ↗
12. Antileishmanial and cytotoxic activities of ionic surfactants compared to those of miltefosine10.1016/j.colsurfb.2019.110421 ↗
13. What can we learn about amphiphile-membrane interaction from model lipid membranes?10.1016/j.bbamem.2021.183781 ↗
14. In search of a novel target - Phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy10.1016/j.bbamem.2011.07.026 ↗
15. Phosphatidylserine: a cancer cell targeting biomarker10.1016/j.semcancer.2017.08.012 ↗
16. Unraveling cholesterol-dependent interactions of alkylphospholipids with supported lipid bilayers10.1021/acs.langmuir.4c04598 ↗
17. Cholesterol stiffening of lipid Membranes10.1007/s00232-022-00263-9 ↗
18. Interaction of miltefosine with microcavity supported lipid membrane: biophysical insights from electrochemical impedance spectroscopy10.1002/elan.202060424 ↗
19. The effects of miltefosine on the structure and dynamics of DPPC and DPPS liposomes mimicking normal and cancer cell membranes: FTIR and DSC studies10.1016/j.molliq.2022.119041 ↗
20. Investigation of miltefosine-model membranes interactions at the molecular level for two different PS levels modeling cancer cells10.1007/s10863-024-10025-y ↗
21. Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH (edelfosine), a proapoptotic agent in tumor cells10.2174/1389200023337225 ↗
22. Premicelles and monomer exchange in aqueous surfactant solutions above and below the critical micelle concentration10.1016/j.cplett.2011.11.075 ↗
23. Hexadecylphosphocholine interaction with lipid monolayers10.1016/j.bbamem.2004.01.010 ↗
24. Surface-active properties of the antitumour ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (edelfosine)10.1016/j.bbamem.2007.04.025 ↗
25. Miltefosine and BODIPY-labeled alkylphosphocholine with leishmanicidal activity: aggregation properties and interaction with model membranes10.1016/j.bpc.2014.10.002 ↗
26. Synthesis and evaluation of antitumor alkylphospholipid prodrugs10.1007/s11095-020-02830-y ↗
27. Solvent-assisted preparation of supported lipid bilayers10.1038/s41596-019-0174-2 ↗
28. Controlled solvent-exchange deposition of phospholipid membranes onto solid surfaces10.1116/1.3319326 ↗
29. Interfacial binding dynamics of bee venom phospholipase A2 investigated by dynamic light scattering and quartz crystal microbalance10.1021/la903117x ↗
30. Solvent-assisted lipid self-assembly at hydrophilic surfaces: factors influencing the formation of supported membranes10.1021/la5048497 ↗
31. Self-assembly formation of lipid bilayer coatings on bare aluminum oxide: overcoming the force of interfacial water10.1021/am507651h ↗
32. The use of quartz oscillators for weighing thin layers and for microweighing10.1007/BF01337937 ↗
33. Adsorption properties of polyelectrolyte-surfactant complexes on hydrophobic surfaces studied by QCM-D10.1021/la061118h ↗
34. QCM-D sensitivity to protein adsorption reversibility10.1002/bit.21977 ↗
35. Understanding miltefosine–membrane interactions using molecular dynamics simulations10.1021/acs.langmuir.5b00178 ↗
36. Ion-binding to phospholipids: interaction of calcium with phosphatidylserine10.1111/j.1432-1033.1976.tb10165.x ↗
37. On the nature of calcium ion binding between phosphatidylserine lamellae10.1021/bi00367a071 ↗
38. Formation of supported membranes from vesicles10.1103/PhysRevLett.84.5443 ↗
39. Intact vesicle adsorption and supported biomembrane formation from vesicles in solution: influence of surface chemistry, vesicle size, temperature, and osmotic pressure10.1021/la0263920 ↗
40. Steric effects on the configuration at nitrogen in piperidines10.1021/ja00766a025 ↗
41. Significance of receptor mobility in multivalent binding on lipid membranes
42. Effect of the electrostatic charge on the mechanism inducing liposome solubilization: a kinetic study by synchrotron radiation SAXS10.1021/la035972+ ↗
43. Interactions of surfactants with lipid membranes10.1017/S0033583508004721 ↗
44. Predicting the packing parameter for lipids in monolayers with the use of molecular dynamics10.1016/j.colsurfb.2021.112298 ↗
45. Differential impact of synthetic antitumor lipid drugs on the membrane organization of phosphatidic acid and diacylglycerol monolayers10.1016/j.chemphyslip.2020.104896 ↗
46. Interactions of antileishmanial drugs with monolayers of lipids used in the development of amphotericin B–miltefosine-loaded nanocochleates10.1016/j.colsurfb.2013.01.041 ↗
47. Alkylphospholipids act through stabilization of planar membranes and inhibition of membrane budding and fusion10.1016/j.jcis.2025.138382 ↗
48. Combination of the anti-tumour cell ether lipid edelfosine with sterols abolishes haemolytic side effects of the drug10.1007/s12154-008-0009-z ↗
49. Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy10.1126/scitranslmed.3007646 ↗
50. Role of phosphatidylserine binding in tissue distribution of amine-containing basic compounds10.1517/17425255.2011.548805 ↗